| Literature DB >> 21744341 |
Wilko Thiele1, Natalia Novac, Sigrun Mink, Caroline Schreiber, Diana Plaumann, Johannes Fritzmann, Natascha Cremers, Melanie Rothley, Christian Schwager, Thomas Regiert, Peter E Huber, Ulrike Stein, Peter Schlag, Jürgen Moll, Amir Abdollahi, Jonathan P Sleeman.
Abstract
We have previously reported that over-expression of a panel of 119 genes correlates with the metastatic potential of pancreatic carcinoma cells. We sought to identify and functionally characterize candidate tumour metastasis promoting genes among this library using a secondary phenotype-assisted screen. Here we report the discovery of the metastasis-promoting function of a hitherto not characterized gene located on chromosome 14 (ORF138), which we have named 'novel metastasis-promoting gene 1' (NVM-1). The NVM-1 transcript is extensively alternatively spliced, is expressed endogenously in a number of different tissues, and is strongly over-expressed at the protein level in a variety of human tumour types. Importantly, NVM-1 expression stimulates the migratory and invasive behaviour of tumour cells and promotes metastasis formation in experimental animals in vivo. Up-regulation of FMNL2 and MT1E and down-regulation of TIMP4 and MHC-I is observed as a consequence of NVM-1 expression. Together these data identify NVM-1 as a gene that is functionally involved in tumour metastasis, and suggest that NVM-1 may constitute a promising therapeutic target for inhibition of tumour metastasis.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21744341 DOI: 10.1002/path.2924
Source DB: PubMed Journal: J Pathol ISSN: 0022-3417 Impact factor: 7.996